Eppendorf India partners with Stilla Technologies

Eppendorf India will distribute the products of Stilla Technologies in India, Bangladesh, Nepal and Sri Lanka.  The...

April 28, 2022 | Thursday | News
Pakistan receives funding worth $11.7 M for mix-and-match trial of COVID-19 vaccines

Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Aga Khan University (AKU) have announced a n...

November 25, 2021 | Thursday | News
Bangladesh inks COVID-19 vaccine production agreement with China

An agreement has been signed between the Sinopharm of China, Ministry of Health and Family Welfare, People’s Repub...

August 17, 2021 | Tuesday | News
Sri Lanka receives first batch of Pfizer COVID-19 vaccines

A consignment of Pfizer vaccines arrived in Colombo on 5th July, the first batch of 800,000 doses to be delivered in the...

July 6, 2021 | Tuesday | News
ADB approves loan worth $940 M for Bangladesh to purchase COVID-19 vaccines

The Asian Development Bank (ADB) has approved a loan package of $940 million for the Government of Bangladesh to purchas...

June 23, 2021 | Wednesday | News
Digital Diagnostics, Orbis International to enhance eye care in Bangladesh

Digital Diagnostics, developers of IDx-DR, an FDA De Novo-cleared autonomous AI system for the detection of diabeti...

June 15, 2021 | Tuesday | News
Bangladesh approves Sputnik V vaccine

The Russian Direct Investment Fund (RDIF) announces that the Directorate General of Drug Administration (DGDA) under the...

April 28, 2021 | Wednesday | News
IVI inks MoU with the Nepal Health Research Council

The International Vaccine Institute (IVI) in South Korea and the Nepal Health Research Council (NHRC) have s...

March 15, 2021 | Monday | News
Pakistan approves Sputnik V COVID-19 vaccine

The Russian Direct Investment Fund (RDIF) announces the Sputnik V vaccine against coronavirus has been approved by ...

February 10, 2021 | Wednesday | News
Neusoft Medical, DEA push Sino-Pakistan cooperation in healthcare

China based Neusoft Medical Systems Co, Ltd (Neusoft Medical) has announced the cloud signing of a memorandum of underst...

December 23, 2020 | Wednesday | News
Hester Biosciences Nepal unveils live thermo-tolerant PPR vaccine

Hester Nepal recently got the regulatory approval and marketing authorisation from Department of Drug Administration (DD...

November 23, 2020 | Monday | News
GCI extends programmes to Bangladesh for underserved cancer patients

Global Cancer Institute (GCI), which is focused on improving survival rates for underserved cancer patients worldwi...

October 30, 2020 | Friday | News
RDIF, Trinity Pharma to supply 25M doses of Sputnik V to Nepal

The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and one of the leading pharmaceutical d...

September 29, 2020 | Tuesday | News
eGeneration partners with Bangladesh govt to tackle pandemic

The COVID-19 pandemic has shaken the whole world and Bangladesh is no different. The country has observed th...

September 16, 2020 | Wednesday | News
Korean CRO to conduct Ph III trial of Sinovac's Covid-19 vaccine candidate in Bangladesh

Korea's LSK Global PS, a leading CRO to run Sinovac Phase III COVID-19 vaccine trial in Bangladesh. The company would m...

September 4, 2020 | Friday | News
Beximco inks COVID-19 vaccine pact with Serum Institute of India

Beximco Pharmaceuticals Limited (BPL) in Bangladesh and the Serum Institute of India Pvt. Ltd (SII), have announced an a...

August 31, 2020 | Monday | News
Eli Lilly & HPL launch once-a-week T2D drug in Bangladesh

Bangladesh based Healthcare Pharmaceuticals Ltd. (HPL) and Eli Lilly & Company recently announced the...

August 10, 2020 | Monday | News
ICCBS- Karachi signs MoU with Chinese Institute on S&T

The International Centre for Chemical and Biological Sciences, University of Karachi (ICCBS) and Tianjin Institute of In...

January 15, 2019 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls